# Sechenov University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/sechenov-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 55 |
| Citations | 942,153 |
| City | Moscow |
| Country | RU |
| Description | Sechenov University is a research organisation in Moscow, RU. OpenAlex records 41,883 works and 942,153 citations for it. 16,586 researchers list it as their most recent affiliation. |
| Homepage | https://www.sechenov.ru/ |
| OpenAlex ID | https://openalex.org/I17877952 |
| Region | Moscow |
| Researchers | 16,586 |
| ROR ID | https://ror.org/02yqqv993 |
| Type | education |
| Works | 41,883 |

## University papers

Showing 12 of 15.

- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-squamous-cell-non-small-cell-lung-cancer/)
- [Oxidative Damage Is the Earliest Event in Alzheimer Disease](https://scholariq.org/papers/oxidative-damage-is-the-earliest-event-in-alzheimer-disease/)
- [EAACI Molecular Allergology User's Guide](https://scholariq.org/papers/eaaci-molecular-allergology-user-s-guide/)
- [Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-previously-treated-patients-with-advanced-non/)
- [Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission](https://scholariq.org/papers/pragmatic-solutions-to-reduce-the-global-burden-of-stroke-a-world-stroke/)
- [Practical guide to skin prick tests in allergy to aeroallergens](https://scholariq.org/papers/practical-guide-to-skin-prick-tests-in-allergy-to-aeroallergens/)
- [IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper](https://scholariq.org/papers/ige-allergy-diagnostics-and-other-relevant-tests-in-allergy-a-world-allergy/)
- [Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment](https://scholariq.org/papers/microarrayed-allergen-molecules-diagnostic-gatekeepers-for-allergy-treatment/)
- [Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper](https://scholariq.org/papers/biomarkers-for-monitoring-clinical-efficacy-of-allergen-immunotherapy-for/)
- [Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life](https://scholariq.org/papers/evolution-and-predictive-value-of-ige-responses-toward-a-comprehensive-panel-of/)
- [Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer](https://scholariq.org/papers/ensartinib-vs-crizotinib-for-patients-with-anaplastic-lymphoma-kinase-positive/)

## University top topics

Showing 8 of 25.

- [Healthcare Systems and Public Health](https://scholariq.org/topics/healthcare-systems-and-public-health/)
- [Neurological Disorders and Treatments](https://scholariq.org/topics/neurological-disorders-and-treatments-2/)
- [Human Health and Disease](https://scholariq.org/topics/human-health-and-disease/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Medical and Biological Sciences](https://scholariq.org/topics/medical-and-biological-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.